Nifty 50
- HDFC Life Insurance ₹526.1512.15 (2.36%)
- HCL Technologies₹1,207-22.80 (-1.85%)
- Power Grid Corp₹271.755.90 (2.22%)
- Hindalco Industries₹1,014-12.90 (-1.26%)
- ONGC₹237.273.25 (1.39%)
- Tata Steel₹186.78-1.97 (-1.04%)
- Bharti Airtel₹1,83924.30 (1.34%)
- Adani Enterprises₹3,077.20-27.50 (-0.89%)
- Tech Mahindra₹1,525.8017.80 (1.18%)
- Mahindra & Mahindra₹3,123.80-26.20 (-0.83%)
- SBI Life Insurance ₹1,700.6016.60 (0.99%)
- Tata Motors PV₹300.50-2.50 (-0.83%)
- HDFC Bank₹693.806.70 (0.98%)
- Apollo Hospitals₹8,900-67.00 (-0.75%)
- SBI₹1,009.709.20 (0.92%)
- InterGlobe Aviation₹4,945-30.00 (-0.60%)
- Shriram Finance₹1,0389.00 (0.87%)
- ITC₹259.30-1.50 (-0.58%)
- L&T₹3,95532.40 (0.83%)
- Nestle₹1,386.20-6.80 (-0.49%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Syncom Formulation Share Price Today
As of 10-09-2026 16:47, Syncom Formulation (India) Ltd. share price today is ₹0, with a change of ₹-20.14 (-100.00%) from the previous close of ₹20.14. The stock opened at ₹20.25 and traded between ₹19.06 and ₹20.28, with a total traded volume of 8403583 shares. The company has a market capitalization of ₹1971.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹22.59 and ₹10.21, respectively.
Syncom Formulation (India) Ltd. valuation metrics include a P/E ratio of 23, EPS of ₹0.81, and book value of ₹4.50. Profitability indicators show ROE of 18.41%. Syncom Formulation (India) Ltd. has reported revenue of ₹497.8 Cr and net profit of ₹85.53 Cr.
Syncom Formulation (India) Ltd. technical indicators include Day RSI at 75.07, Day MFI at 85.54, Day ADX at 56.2. Additional indicators include Commodity Channel Index (CCI) at 104.1 and Williams %R at -22.5. Momentum indicators show Day MACD at 1.76, Day MACD Signal Line at 1.48, DayATR at 1.17. Rate of Change indicators for Syncom Formulation (India) Ltd. include ROC125 at 74.9 and ROC21 at 46.23.
Exponential moving averages include EMA5 at ₹20.6, EMA10 at ₹19.8, EMA12 at ₹19.4, EMA20 at ₹18.3, EMA26 at ₹17.7, EMA50 at ₹16.2, EMA100 at ₹15.2, EMA200 at ₹15. Simple moving averages include SMA5 at ₹20.9, SMA10 at ₹19.8, SMA20 at ₹17.8, SMA30 at ₹16.4, SMA50 at ₹15.3, SMA100 at ₹14.8, SMA150 at ₹14.1, SMA200 at ₹14.1.
Support levels for Syncom Formulation are placed at First Support ₹20.41, Second Support ₹19.86, Third Support ₹19.31. Resistance levels are seen at First Resistance ₹21.51, Second Resistance ₹22.06, Third Resistance ₹22.61. Syncom Formulation (India) Ltd. shareholding pattern shows promoter holding at 50.57%, FII holding at 0.35%, DII holding at 0%, public holding at 49.07%.
Syncom Formulation Performance
Price Movement
₹19.06
₹20.28
1 Year Performance
₹10.21
₹22.59
Markets Today
Historical Performance
Syncom Formulation Fundamentals
Syncom Formulation Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 124.66 | 134 | 114.59 | 121.44 | 116.55 |
| Operating Expense | 98.80 | 112.51 | 93.42 | 102.71 | 100.77 |
| Operating Profit | 25.86 | 21.49 | 21.17 | 18.72 | 15.77 |
| Depreciation | 1.54 | 2.48 | 1.36 | 1.35 | 1.34 |
| Interest | 0.23 | 0.37 | 0.25 | 0.25 | 0.24 |
| Tax | 7.32 | 8.29 | 6.18 | 5.52 | 4.53 |
| Net Profit | 24.59 | 24.57 | 18.86 | 16.84 | 15.73 |
Syncom Formulation Technicals
Syncom Formulation (India) Ltd. EMA & SMA
₹19.23
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Syncom Formulation Support and Resistance
Resistance
Support
Technical Indicators
Syncom Formulation Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 50.6 | 50.6 | 50.6 | 50.6 | 50.6 | 50.6 |
| FII | 0.1 | 0.4 | 0.1 | 0.3 | 0.2 | 0.4 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 49.3 | 49 | 49.3 | 49.2 | 49.2 | 49.1 |
Syncom Formulation Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 40.58 L | 1.33 Cr | 30.44% |
| Week | 70.54 L | 2.04 Cr | 34.54% |
| 1 Month | 50.94 L | 1.66 Cr | 30.61% |
| 6 Month | 18.49 L | 49.16 L | 37.61% |
Syncom Formulation SWOT Analysis
High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Affordable Stocks with High ROE and Momentum
Companies with high TTM EPS Growth
Stringent DVM Screener
Weekly Screener: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Syncom Formulation Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 23 Sep, 2026 | 0.1 | FINAL | 23 Sep, 2026 | Equity Share |
| 09 Sep, 2022 | 0.03 | FINAL | Equity Share | |
| 21 Sep, 2017 | 0.02 | FINAL | Equity Share | |
| 22 Sep, 2016 | 0.02 | FINAL | Equity Share | |
| 16 Sep, 2015 | 0.02 | FINAL | Equity Share | |
| 18 Sep, 2014 | 0.02 | FINAL | Equity Share | |
| 10 Jul, 2013 | 0.6 | FINAL | Equity Share | |
| 20 Sep, 2012 | 0.6 | FINAL | Equity Share | |
| 22 Sep, 2011 | 0.5 | FINAL | Equity Share | |
| 23 Sep, 2010 | 0.5 | FINAL | Equity Share |
Syncom Formulation Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹160 | ₹521 | ₹6.15 | ₹209 | ₹201.78 | ₹17.80 |
| % Change | -0.28% | -0.98% | -1.91% | -4.41% | -2.00% | 9.34% |
| Revenue TTM (₹ Cr) | - | ₹526.28 | ₹69.99 | - | ₹291.17 | ₹226.23 |
| Net Profit TTM (₹ Cr) | - | ₹20.77 | ₹-176.47 | - | ₹14.68 | ₹31.63 |
| PE TTM | 12.30 | 112.70 | -0.30 | 23.20 | 53.40 | 2.60 |
| 1 Year Return | 14.86 | 35.13 | 533 | 55.31 | 60.21 | 61.43 |
| ROCE | 34.19 | 3.56 | -56.37 | - | - | 17.36 |
Similar Stocks
MEDISTEP
Medistep Healthcare Ltd.
₹ 23.40
+0.00%
INFLUX
Influx Healthtech Ltd.
₹ 277.80
+0.07%
RPGLIFE
RPG Life Sciences Ltd.
₹ 2780.00
-1.14%
BAFNAPH
Bafna Pharmaceuticals Ltd.
₹ 307.60
+1.99%
ALPA
Alpa Laboratories Ltd.
₹ 62.19
-1.66%
SMSPHARMA
SMS Pharmaceuticals Ltd.
₹ 416.00
+2.14%
NECLIFE
Nectar Lifesciences Ltd.
₹ 11.90
-0.67%
MANGALAM
Mangalam Drugs and Organics Ltd.
₹ 34.88
+10.00%
INDOCO
Indoco Remedies Ltd.
₹ 258.00
+11.60%
INDSWFTLAB
Ind-Swift Laboratories Ltd.
₹ 379.00
-2.46%
LINCOLN
Lincoln Pharmaceuticals Ltd.
₹ 636.70
-0.13%
PANACEABIO
Panacea Biotec Ltd.
₹ 388.00
-1.47%
MEDICAMEQ
Medicamen Biotech Ltd.
₹ 302.00
-3.48%
THEMISMED
Themis Medicare Ltd.
₹ 132.84
+0.10%
VENUSREM
Venus Remedies Ltd.
₹ 1623.00
-1.65%
BALPHARMA
Bal Pharma Ltd.
₹ 105.50
-7.82%
HIKAL
Hikal Ltd.
₹ 234.10
-2.74%
NGLFINE
NGL Fine - Chem Ltd.
₹ 2720.00
-1.39%
HESTERBIO
Hester Biosciences Ltd.
₹ 2270.00
-2.26%
NATCAPSUQ
Natural Capsules Ltd.
₹ 192.77
-0.77%
KREBSBIO
Krebs Biochemicals & Industries Ltd.
₹ 61.00
+1.43%
KILITCH
Kilitch Drugs(I) Ltd.
₹ 185.92
-1.34%
AAREYDRUGS
Aarey Drugs & Pharmaceuticals Ltd.
₹ 94.99
-4.99%
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Ltd.
₹ 36.00
+14.43%
FAQ's on SYNCOMF
What is the current share price of Syncom Formulation (India) Ltd.?
What is the Market Capitalization of Syncom Formulation (India) Ltd.?
What are the PE and PB ratios for Syncom Formulation (India) Ltd.?
What is the 52-Week High and Low for Syncom Formulation (India) Ltd.?
Who are the major shareholders of Syncom Formulation (India) Ltd.?
Who are the peers of Syncom Formulation (India) Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Syncom Formulation (India) Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy